司巴沙星(sparfloxacin)是近些年来开发的高效新喹诺酮类抗菌药物。本药对革蓝氏阳性菌、革蓝氏阴性菌等有广泛的抗菌谱,特别是比以往的喹诺酮类抗菌药物具有更强的抗菌谱,包括肺炎球菌、葡萄球菌在内的革蓝氏阳性菌,从而改善了其它喹诺酮类抗菌药物不宜用作治疗呼吸系统感染的 Sparfloxacin is a highly effective new quinolone antibacterial agent developed in recent years. The drug against Gram-positive bacteria, Gram-negative bacteria such as a wide range of antibacterial spectrum, especially than the previous quinolone antibacterial drugs have a more antimicrobial spectrum, including pneumococcus, Staphylococcus aureus, including the blue-positive Bacteria, thereby improving the other quinolone antibiotics should not be used for the treatment of respiratory infections